(Q24795469)

2

object named as

Kirsten B Moysich

0 references

author name string

Helena Furberg

3

0 references

Jo L Freudenheim

4

0 references

Elise D Bowman

5

0 references

Sabrina Ahmed

6

0 references

Saxon Graham

7

0 references

John E Vena

8

0 references

Peter G Shields

CYP17 genotype and breast cancer risk

9

0 references

language of work or name

English

0 references

publication date

2003

0 references

published in

Breast Cancer Research

0 references

volume

5

0 references

issue

2

0 references

page(s)

R45-51

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=154148

NF-1C, Sp1, and Sp3 are essential for transcription of the human gene for P450c17 (steroid 17alpha-hydroxylase/17,20 lyase) in human adrenal NCI-H295A cells

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=154148

Steroid metabolism gene CYP17 polymorphism and the development of breast cancer.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=154148

A systematic review of genetic polymorphisms and breast cancer risk.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=154148

No association between a polymorphism in the steroid metabolism gene CYP17 and risk of breast cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=154148

Gene regulation of steroidogenesis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=154148

Cytochrome P450c17alpha gene (CYP17) polymorphism predicts use of hormone replacement therapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=154148

Premenopausal breast cancer risk and intake of vegetables, fruits, and related nutrients

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=154148

Nutritional epidemiology of postmenopausal breast cancer in western New York

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=154148

Association between CYP17 gene polymorphism and risk of breast cancer in young women.

30 May 2018

1 reference

Re: CYP17 promoter polymorphism and breast cancer in Australian women under age forty years

21 January 2018

1 reference

CYP17 polymorphism in the groups of distinct breast cancer susceptibility: comparison of patients with the bilateral disease vs. monolateral breast cancer patients vs. middle-aged female controls vs. elderly tumor-free women.

21 January 2018

1 reference

No association of the 5' promoter region polymorphism of CYP17 with breast cancer risk in Japan.

21 January 2018

1 reference

Building a multigenic model of breast cancer susceptibility: CYP17 and HSD17B1 are two important candidates.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=154148

Cytochrome P450c17alpha gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=154148

A polymorphism in intron 6 of the CYP17 gene

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=154148

Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility

28 November 2018

1 reference

12 December 2020

CYP17 promoter polymorphism and breast cancer in Australian women under age forty years

1 reference

12 December 2020

Genetic polymorphism in CYP17 and breast cancer risk in Japanese women

1 reference

12 December 2020

The CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis

1 reference

12 December 2020

Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17

1 reference

12 December 2020

Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk

1 reference

12 December 2020

A polymorphism in the CYP17 gene increases the risk of breast cancer

1 reference

12 December 2020

Association between CYP17 polymorphisms and the development of breast cancer

1 reference

12 December 2020

The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer

1 reference

12 December 2020

CYP17 and breast cancer risk: the polymorphism in the 5' flanking area of the gene does not influence binding to Sp-1

1 reference

12 December 2020